This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $5,455.38 firm fixed-price contract is for the delivery of ATOVAQUONE-PROGUANIL 250-100 100S, a pharmaceutical product. The contract has an ultimate completion date of November 5, 2024. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers nationwide. This contract is not associated with a set-aside designation, allowing DMS Pharmaceutical Group Inc. to leverage its status as a woman-owned small business to secure direct federal awards across multiple product categories. The company also holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $499,999,999 and valid through November 2026, for the provision of a wide range of pharmaceutical products to support the medical supply needs of Department of Defense healthcare sites.
Generated 2/3/25, 1:21 PM